A new venture from Amazon, JP Morgans and Berkshire Hathaway has US healthcare in its crosshairs. It may also offer opportunities for innovators in health IT and digital medicine.
Volume 36 Issue 3, March 2018
T cell receptor (TCR) gene therapy can target the immune system to solid tumors in ways CAR-T cells can't match, but the field is still looking for a clear success. Ken Garber reports.
News & Views
Using deep learning to combine target sequence and chromatin accessibility data boosts the accuracy of CRISPR–Cpf1 guide RNA activity
Engineered switchgrass and poplar are better feedstocks for biofuel synthesis and yield more biomass in multi-year field trials.
DNA origami-based nanorobot presents thrombin to cause tumor infarction after specific recognition of a tumor vessel marker.
Large-scale integration of metabolite and protein structural data with existing networks of human metabolism provides insights into gene function and how drugs affect metabolic response.
Careers and Recruitment
With mental illness a growing concern within graduate education, data from a new survey should prompt both academia and policy makers to consider intervention strategies.